Assyro AI

Orange Book product · Generic (ANDA)

SODIUM OXYBATE

SODIUM OXYBATE

Generic (ANDA)ANDA 210523TE AARX ASCENT PHARMS INC

At a glance

Nov 05, 2025

Approved

Generic (ANDA)

Application

AA

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Nov 05, 2025

    8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

SODIUM OXYBATE

Strength

0.5GM/ML

Dosage form

SOLUTION

Route

ORAL

TE code

AA

Application

ANDA 210523

Product number

001

Marketing status

RX

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of SODIUM OXYBATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.